期刊
CELL DEATH DISCOVERY
卷 7, 期 1, 页码 -出版社
SPRINGERNATURE
DOI: 10.1038/s41420-021-00440-0
关键词
-
类别
资金
- National Natural Science Foundation of China [82070675, 81871259, 81530048, 81971495, 81570562]
- Foundation of Jiangsu Collaborative Innovation Center of Biomedical Functional Materials
- Priority Academic Program Development of Jiangsu Higher Education Institutions
- Six talent peaks project in Jiangsu Province [2017-WSW-019]
Research indicates that miR-23b-5p acts as a tumor suppressor in HCC by inducing G0/G1 cell cycle arrest and inhibiting cell proliferation. It targets FOXM1 to regulate cyclin D1 and c-MYC expression, suggesting it may serve as a potential biomarker for HCC diagnosis and prognosis.
Growing evidence demonstrates that MicroRNAs (miRNAs) play an essential role in contributing to tumor development and progression. However, the underlying role and mechanisms of miR-23b-5p in hepatocellular carcinoma (HCC) formation remain unclear. Our study showed that miR-23b-5p was downregulated in the HCC tissues and cell lines, and lower expression of miR-23b-5p was associated with more severe tumor size and poorer survival. Gain- or loss-of-function assays demonstrated that miR-23b-5p induced G0/G1 cell cycle arrest and inhibited cell proliferation both in vitro and in vivo. qRT-PCR, western blot and luciferase assays verified that Mammalian transcription factor Forkhead Box M1 (FOXM1), upregulated in HCC specimens, was negatively correlated with miR-23b-5p expression and acted as a direct downstream target of miR-23b-5p. In addition, miR-23b-5p could regulate cyclin D1 and c-MYC expression by directly targeting FOXM1. Further study revealed that restoration of FOXM1 neutralized the cell cycle arrest and cell proliferation inhibition caused by miR-23b-5p. Taken together, our findings suggest that miR-23b-5p acted as a tumor suppressor role in HCC progression by targeting FOXM1 and may serve as a potential novel biomarker for HCC diagnosis and prognosis.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据